A touch-screen based paired-associates learning (PAL) task for the rat may provide a translatable pharmacological model of human cognitive impairment

The use of touch-screen equipped operant boxes is an increasingly popular approach for modeling human cognition in the rodent. However little data is currently available describing the effects of pharmacological manipulations on touch-screen based tasks. Owing to the relationship between performance on visual-spatial paired associates learning (PAL) with schizophrenia and Alzheimer's disease one task of specific interest is the touch-screen PAL task developed for rodents (J. Talpos et al., 2009). The goal of this study was to profile a range of the commonly used pharmacological models of schizophrenia and Alzheimer's disease to investigate the sensitivity of PAL to these models of disease. Male Lister hooded rats were trained on PAL until stable performance was obtained. The effects of PCP, ketamine, amphetamine, LSD, scopolamine, and biperiden (recently proposed as an alternative to scopolamine) were then tested on animals performing the PAL task. While all compounds influenced responding during PAL, only PCP and amphetamine impaired performance with minimal changes in secondary measures (response latencies, trials completed). Surprisingly ketamine did not cause a change in percent correct despite being an NMDA antagonist, indicating that not all NMDA antagonists are equal in the touch-screen platform. This finding is in agreement with existing literature showing differential effects of NMDA antagonists on a wide variety of behavioral assays include tasks of attention, memory, and cognitive flexibility (Gilmour et al., 2009; Dix et al., 2010; Smith et al., 2011). Moreover biperiden showed no benefit when compared to scopolamine, highlighting the current lack of an effective pharmacological model of cholinergic dysfunction in the touch-screen platform. These data demonstrate that performance on PAL can be disrupted by common pharmacological disease models, suggesting that PAL may have the sensitivity to serve as a translational test for the study of cognition in humans.

[1]  G. Lynch,et al.  Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5 , 1986, Nature.

[2]  L. Saksida,et al.  The touchscreen cognitive testing method for rodents: how to get the best out of your rat. , 2008, Learning & memory.

[3]  R. Clark,et al.  Rats depend on habit memory for discrimination learning and retention. , 2007, Learning & memory.

[4]  L. Gold,et al.  Differential muscarinic and NMDA contributions to visuo-spatial paired-associate learning in rhesus monkeys , 2002, Psychopharmacology.

[5]  T. Robbins,et al.  Hippocampal dysfunction in patients with mild cognitive impairment: A functional neuroimaging study of a visuospatial paired associates learning task , 2011, Neuropsychologia.

[6]  J. Sirviö,et al.  The 5-HT2 Receptor Activation Enhances Impulsive Responding Without Increasing Motor Activity in Rats , 2000, Pharmacology Biochemistry and Behavior.

[7]  T. Svensson,et al.  Effects of d-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat , 1995, Behavioural Brain Research.

[8]  L. Saksida,et al.  A computer-automated touchscreen paired-associates learning (PAL) task for mice: impairments following administration of scopolamine or dicyclomine and improvements following donepezil , 2011, Psychopharmacology.

[9]  R. Lester,et al.  Synaptic activation of N‐methyl‐D‐aspartate receptors in the Schaffer collateral‐commissural pathway of rat hippocampus. , 1988, The Journal of physiology.

[10]  Franz X Vollenweider,et al.  Serotonin research: contributions to understanding psychoses. , 2008, Trends in pharmacological sciences.

[11]  U. Ebert,et al.  Scopolamine model of dementia: electroencephalogram findings and cognitive performance , 1998, European journal of clinical investigation.

[12]  Peter B. Jones,et al.  Visuospatial learning and executive function are independently impaired in first-episode psychosis , 2005, Psychological Medicine.

[13]  Arjan Blokland,et al.  The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies , 2010, Neuroscience & Biobehavioral Reviews.

[14]  P. Rabbitt,et al.  Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. , 1994, Dementia.

[15]  M. Carli,et al.  Serotonin2 receptor agonists and serotonergic anorectic drugs affect rats’ performance differently in a five-choice serial reaction time task , 2007, Psychopharmacology.

[16]  H. Emrich,et al.  The Pharmacology of Lysergic Acid Diethylamide: A Review , 2008, CNS neuroscience & therapeutics.

[17]  B. Moghaddam,et al.  Impact of metabotropic glutamate 2/3 receptor stimulation on activated dopamine release and locomotion , 2010, Psychopharmacology.

[18]  R. Roth,et al.  The Neuropsychopharmacology of Phencyclidine: From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia , 1999, Neuropsychopharmacology.

[19]  P. Tariot,et al.  Pharmacologic modelling of Alzheimer's disease , 1986, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[20]  D. M. Grilly,et al.  What is a "low dose" of d-amphetamine for inducing behavioral effects in laboratory rats? , 2000, Psychopharmacology.

[21]  Daniel C. Javitt,et al.  Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: Implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function , 2008, Neurochemistry International.

[22]  The pharmacological sensitivity of a touchscreen-based visual discrimination task in the rat using simple and perceptually challenging stimuli , 2012, Psychopharmacology.

[23]  C. Tamminga,et al.  Schizophrenia and glutamatergic transmission. , 1998, Critical reviews in neurobiology.

[24]  L. Saksida,et al.  A novel touchscreen-automated paired-associate learning (PAL) task sensitive to pharmacological manipulation of the hippocampus: a translational rodent model of cognitive impairments in neurodegenerative disease , 2009, Psychopharmacology.

[25]  P. Bonaventure,et al.  Comparison of the ex vivo receptor occupancy profile of ketamine to several NMDA receptor antagonists in mouse hippocampus. , 2013, European journal of pharmacology.

[26]  P. Chapman,et al.  Effect of donepezil on reversal learning in a touch screen-based operant task , 2009, Behavioural pharmacology.

[27]  P. White,et al.  Effects of halothane anesthesia on the biodisposition of ketamine in rats. , 1976, The Journal of pharmacology and experimental therapeutics.

[28]  Richard D Emes,et al.  Synaptic scaffold evolution generated components of vertebrate cognitive complexity , 2012, Nature Neuroscience.

[29]  Janice W. Smith,et al.  A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory , 2011, Psychopharmacology.

[30]  Adrian M. Owen,et al.  Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man , 1995, Neuropsychologia.

[31]  R. Lester,et al.  Frequency‐dependent N‐methyl‐D‐aspartate receptor‐mediated synaptic transmission in rat hippocampus. , 1988, The Journal of physiology.

[32]  L. Saksida,et al.  New translational assays for preclinical modelling of cognition in schizophrenia: The touchscreen testing method for mice and rats , 2012, Neuropharmacology.

[33]  A. Blokland,et al.  A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment , 2011, Psychopharmacology.

[34]  L. Saksida,et al.  Trial-unique, delayed nonmatching-to-location (TUNL): A novel, highly hippocampus-dependent automated touchscreen test of location memory and pattern separation , 2010, Neurobiology of Learning and Memory.

[35]  R. J. McDonald,et al.  A triple dissociation of memory systems: Hippocampus, amygdala, and dorsal striatum. , 1993, Behavioral neuroscience.

[36]  Michael F. Green,et al.  Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria , 2004, Biological Psychiatry.

[37]  Thomas Steckler,et al.  Touching on translation , 2013, Cell and Tissue Research.

[38]  Janice W. Smith,et al.  A within-subject cognitive battery in the rat: differential effects of NMDA receptor antagonists , 2010, Psychopharmacology.

[39]  B. Moghaddam,et al.  Corticolimbic Dopamine Neurotransmission Is Temporally Dissociated from the Cognitive and Locomotor Effects of Phencyclidine , 1998, The Journal of Neuroscience.

[40]  T. Steckler,et al.  NMDA receptors, cognition and schizophrenia – Testing the validity of the NMDA receptor hypofunction hypothesis , 2012, Neuropharmacology.

[41]  E. sanders-Bush,et al.  Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors , 2002, Neuroscience.

[42]  Inah Lee,et al.  Hippocampus is required for paired associate memory with neither delay nor trial uniqueness. , 2011, Learning & memory.

[43]  T. Robbins,et al.  Effects of scopolamine on delayed-matching-to-sample and paired associates tests of visual memory and learning in human subjects: comparison with diazepam and implications for dementia , 1997, Psychopharmacology.

[44]  T. Robbins,et al.  Assessing cognitive function in clinical trials of schizophrenia , 2010, Neuroscience & Biobehavioral Reviews.

[45]  M. Packard,et al.  Differential effects of fornix and caudate nucleus lesions on two radial maze tasks: evidence for multiple memory systems , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[46]  R. Thisted,et al.  Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis , 2005, Psychopharmacology.

[47]  L. Saksida,et al.  FK962 and donepezil act synergistically to improve cognition in rats: Potential as an add-on therapy for Alzheimer's disease , 2011, Pharmacology Biochemistry and Behavior.

[48]  M. Laruelle,et al.  Neurobiology of dopamine in schizophrenia. , 2007, International review of neurobiology.

[49]  Andrew D. Blackwell,et al.  Detecting Dementia: Novel Neuropsychological Markers of Preclinical Alzheimer’s Disease , 2003, Dementia and Geriatric Cognitive Disorders.

[50]  L R Squire,et al.  Memory and forgetting: long-term and gradual changes in memory storage. , 1994, International review of neurobiology.

[51]  J. Sirviö,et al.  Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task , 2000, Neuropharmacology.

[52]  R. J. McDonald,et al.  Revisiting the cholinergic hypothesis in the development of Alzheimer's disease , 2011, Neuroscience & Biobehavioral Reviews.

[53]  R. Murray,et al.  What can we learn about schizophrenia from studying the human model, drug‐induced psychosis? , 2013, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[54]  Janice W. Smith,et al.  Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for “NMDA antagonist modelling” of schizophrenia , 2009, Psychopharmacology.

[55]  L. Saksida,et al.  Hippocampal lesions in rats impair learning and memory for locations on a touch-sensitive computer screen: The “ASAT” task , 2008, Behavioural Brain Research.

[56]  L. Saksida,et al.  A new touchscreen test of pattern separation: effect of hippocampal lesions , 2009, Neuroreport.

[57]  A. Sahgal,et al.  Psychopharmacological studies in rats responding at touch-sensitive devices , 1995, Psychopharmacology.

[58]  D. Lorrain,et al.  Effects of ketamine and n-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268 , 2003, Neuroscience.

[59]  A. Lawrence,et al.  The Cognitive Psychopharmacology of Alzheimer's Disease: Focus on Cholinergic Systems , 1998, Neurochemical Research.